Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:40 pm Sale |
2024-12-31 | 13G | NextCure, Inc. NXTC |
Logos Global Management LP | 0 0.000% |
-2,500,000 (Position Closed) |
Filing History |
| 2024-11-14 6:59 pm Purchase |
2024-09-30 | 13G | NextCure, Inc. NXTC |
Logos Global Management LP | 2,500,000 8.900% |
499,540 (+24.97%) |
Filing History |
| 2024-11-13 4:06 pm Purchase |
2024-09-30 | 13G | NextCure, Inc. NXTC |
Affinity Healthcare Fund, LP | 2,302,598 8.220% |
629,759 (+37.65%) |
Filing History |
| 2024-06-27 4:47 pm Purchase |
2024-06-20 | 13G | NextCure, Inc. NXTC |
Affinity Healthcare Fund, LP | 1,672,839 5.980% |
1,672,839 (New Position) |
Filing History |
| 2024-04-01 6:34 pm Purchase |
2024-04-01 | 13G | NextCure, Inc. NXTC |
Logos Global Management LP | 2,000,460 7.200% |
2,000,460 (New Position) |
Filing History |
| 2024-03-08 4:34 pm Sale |
2024-03-06 | 13D | NextCure, Inc. NXTC |
ORBIMED ADVISORS LLC | 1,268,013 4.500% |
-1,443,000 (-53.23%) |
Filing History |
| 2024-01-19 4:26 pm Sale |
2023-12-31 | 13G | NextCure, Inc. NXTC |
MILLENNIUM MANAGEMENT LLC | 1,140,389 4.100% |
-309,496 (-21.35%) |
Filing History |
| 2023-02-06 3:02 pm Sale |
2022-12-31 | 13G | NextCure, Inc. NXTC |
Lilly Asia Ventures Fund III L.P. | 0 0.000% |
-1,704,391 (Position Closed) |
Filing History |
| 2023-01-24 4:23 pm Purchase |
2023-01-19 | 13G | NextCure, Inc. NXTC |
MILLENNIUM MANAGEMENT LLC | 1,449,885 5.200% |
1,449,885 (New Position) |
Filing History |
| 2022-02-09 12:20 pm Sale |
2021-12-31 | 13G | NextCure, Inc. NXTC |
Lilly Asia Ventures Fund III L.P. | 1,704,391 6.200% |
-384,468 (-18.41%) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | NextCure, Inc. NXTC |
BLACKROCK INC BLK |
1,204,689 3.200% |
-309,954 (-20.46%) |
Filing History |
| 2021-05-10 4:04 pm Sale |
2021-04-30 | 13G | NextCure, Inc. NXTC |
MORGAN STANLEY MS |
399,919 1.400% |
-1,781,699 (-81.67%) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | NextCure, Inc. NXTC |
GREAT POINT PARTNERS LLC | 0 0.000% |
-1,376,532 (Position Closed) |
Filing History |
| 2021-02-12 10:11 am Sale |
2020-12-31 | 13G | NextCure, Inc. NXTC |
LORD ABBETT & CO | 0 0.000% |
-1,442,300 (Position Closed) |
Filing History |
| 2021-02-11 2:11 pm Purchase |
2020-12-31 | 13G | NextCure, Inc. NXTC |
MORGAN STANLEY MS |
2,181,618 7.900% |
302,638 (+16.11%) |
Filing History |
| 2021-02-03 2:52 pm Sale |
2020-12-31 | 13G | NextCure, Inc. NXTC |
CANAAN X L.P. | 838,442 3.000% |
-1,416,000 (-62.81%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | NextCure, Inc. NXTC |
BLACKROCK INC BLK |
1,514,643 5.500% |
1,514,643 (New Position) |
Filing History |
| 2020-10-26 4:02 pm Purchase |
2020-10-15 | 13G | NextCure, Inc. NXTC |
MORGAN STANLEY MS |
1,878,980 6.800% |
1,878,980 (New Position) |
Filing History |